Highlights
News
28 January 2019

Ola has delivered a series of groundbreaking new algorithms for the traveling salesman problem, one of the most heavily studied and important questions in theoretical computer science. The Michael and Sheila Held Prize is presented annually and carries with it a $100,000 prize. The prize honors outstanding, innovative, creative, and influential research in the areas of combinatorial and discrete optimization, or related parts of computer science, such as the design and analysis of algorithms and complexity theory. Congratulations to Ola for his elegant work on algorithms for discrete optimization problems!

24 July 2019

The pedestrian tunnel of Lugano-Besso changes its appearance. From September 2, 2019, it will host "NeuralRope#1. Inside an Artificial Brain" - an installation that combines artistic and scientific research, between contemporary art and artificial intelligence.

6 August 2019

The SUPSI Council has bestowed the title of Professor of Approximated Algorithms to Fabrizio Grandoni. Fabrizio received his PhD in 2004 from the University of Rome Tor Vergata. He has been a visiting researcher at Berkeley, EPFL, and Bergen. in 2011 he was awarded an ERC Starting Grant from the European Commission and he joined IDSIA here in Manno. His research focuses on the design and (mostly theoretical) analysis of algorithms and data structures to address a variety of problems.

9 October 2019

Artificial Intelligence (AI) is gaining more and more importance in the pharmaceutical sector, deeply transforming the drug discovery process. There are many potential benefits of applying AI techniques to improve the development of new molecules and the identification of new targets, cutting R&D costs and time. In drug discovery, AI helps in predicting the efficacy and safety of molecules. It gives researchers a much broader chemical pallet for the selection of the best molecules for drug testing and delivery. In this context, drug repurposing is another important area where AI can have a substantial impact. With the extensive amount of clinical and pharmaceutical data available to date, AI algorithms find suitable drugs that can be repurposed for an alternative use in medicine. Moreover, with the help of AI, it becomes easier to run clinical tests, diagnose diseases and provide the most effective treatment for a particular disease. As it can interpret test results, AI can also look through various sources including publications to correctly diagnose critical ailments. New approaches based on AI in the drug discovery process and in the repositioning of old molecules will be presented during this particular Forum. We hope to provide an overview of the sectors where AI might have an impact on the pharmaceutical pipeline and play a crucial role in the pharmaceutical world in the coming years. The Forum is organized by IBSA Foundation in collaboration with Andrea Danani (Istituto Dalle Molle di studi sull’intelligenza artificiale-IDSIA, USI e SUPSI). The Forum will be held in English. The entrance is free, with mandatory registration.

st.wwwsupsi@supsi.ch